Bank of New York Mellon’s ImmunityBio IBRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.94M Buy
734,720
+232,451
+46% +$614K ﹤0.01% 2762
2025
Q1
$1.51M Buy
502,269
+2,741
+0.5% +$8.25K ﹤0.01% 2807
2024
Q4
$1.28M Sell
499,528
-5,793
-1% -$14.8K ﹤0.01% 2987
2024
Q3
$1.88M Sell
505,321
-116,215
-19% -$432K ﹤0.01% 2774
2024
Q2
$3.93M Buy
621,536
+170,742
+38% +$1.08M ﹤0.01% 2455
2024
Q1
$2.42M Sell
450,794
-31,641
-7% -$170K ﹤0.01% 2665
2023
Q4
$2.42M Sell
482,435
-35,792
-7% -$180K ﹤0.01% 2729
2023
Q3
$876K Sell
518,227
-3,581
-0.7% -$6.05K ﹤0.01% 3230
2023
Q2
$1.45M Buy
521,808
+81,475
+19% +$227K ﹤0.01% 3006
2023
Q1
$801K Sell
440,333
-9,616
-2% -$17.5K ﹤0.01% 3231
2022
Q4
$2.28M Buy
449,949
+8,451
+2% +$42.8K ﹤0.01% 2786
2022
Q3
$2.2M Buy
441,498
+83,140
+23% +$413K ﹤0.01% 2782
2022
Q2
$1.33M Buy
358,358
+15,580
+5% +$58K ﹤0.01% 3057
2022
Q1
$1.92M Sell
342,778
-11,442
-3% -$64.2K ﹤0.01% 2957
2021
Q4
$2.15M Buy
354,220
+2,640
+0.8% +$16.1K ﹤0.01% 2949
2021
Q3
$3.42M Buy
351,580
+41,531
+13% +$404K ﹤0.01% 2686
2021
Q2
$4.43M Buy
310,049
+143,202
+86% +$2.04M ﹤0.01% 2551
2021
Q1
$3.96M Sell
166,847
-53,330
-24% -$1.27M ﹤0.01% 2554
2020
Q4
$2.94M Buy
220,177
+42,692
+24% +$569K ﹤0.01% 2621
2020
Q3
$1.23M Sell
177,485
-3,357
-2% -$23.3K ﹤0.01% 2993
2020
Q2
$2.22M Buy
180,842
+72,991
+68% +$896K ﹤0.01% 2622
2020
Q1
$311K Sell
107,851
-1,290
-1% -$3.72K ﹤0.01% 3579
2019
Q4
$414K Sell
109,141
-1,485
-1% -$5.63K ﹤0.01% 3681
2019
Q3
$135K Buy
110,626
+31,982
+41% +$39K ﹤0.01% 3969
2019
Q2
$80K Sell
78,644
-81,792
-51% -$83.2K ﹤0.01% 4053
2019
Q1
$254K Buy
160,436
+59,473
+59% +$94.2K ﹤0.01% 3793
2018
Q4
$117K Sell
100,963
-48,489
-32% -$56.2K ﹤0.01% 3933
2018
Q3
$553K Sell
149,452
-20,819
-12% -$77K ﹤0.01% 3595
2018
Q2
$521K Buy
170,271
+49,040
+40% +$150K ﹤0.01% 3613
2018
Q1
$471K Buy
121,231
+178
+0.1% +$692 ﹤0.01% 3607
2017
Q4
$544K Buy
121,053
+3,886
+3% +$17.5K ﹤0.01% 3575
2017
Q3
$642K Sell
117,167
-5,044
-4% -$27.6K ﹤0.01% 3462
2017
Q2
$928K Buy
122,211
+39,823
+48% +$302K ﹤0.01% 3292
2017
Q1
$292K Sell
82,388
-14,225
-15% -$50.4K ﹤0.01% 3755
2016
Q4
$553K Buy
96,613
+11,146
+13% +$63.8K ﹤0.01% 3542
2016
Q3
$666K Buy
85,467
+7,024
+9% +$54.7K ﹤0.01% 3393
2016
Q2
$487K Buy
78,443
+22,155
+39% +$138K ﹤0.01% 3550
2016
Q1
$463K Buy
56,288
+14,965
+36% +$123K ﹤0.01% 3474
2015
Q4
$715K Buy
41,323
+23,763
+135% +$411K ﹤0.01% 3353
2015
Q3
$201K Buy
+17,560
New +$201K ﹤0.01% 3866